Bivalirudin use-an update after the Matrix trial

Bivalirudin use-an update after the Matrix trial

This is the presentation I had at the CCIF meeting at Guiyang, China, April 2015.

Which is the current role of Bivalirudin in ACS patients, nowadays? Did the Matrix trial change the scenario, or created more confusion on the matter?

 

FinalBivalirudin presentation China

BVS Survey 2014

This is the PPTX presentation of the BVS survey 2014, as presented at the BVS Advisory Board of Abbott in March 2015. This is a spontaneous survey dedicated to BVS Expert Users, and I shared this research with M. Valgimigli, Bern.

It is of some interest to see how Experts felt this technology by mid-2014, and a publication in the International Journal of Cardiology followed. Another Survey was depicted in 2015 and we are currently analyzing its results.

I am thus wishing you all a happy New Year!!

BVS survey2